| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING | 4,850 | 0 | 4,850 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| I SHARES MSCI EMERGING MKT | 35,201 | 68,390 |
| I SHARES S&P 500 GROWTH | 52,830 | 301,212 |
| I SHARES S&P 500 VALUE | 44,884 | 109,641 |
| I SHARES RUSSELL 2000 | 17,898 | 55,613 |
| BIOMARIN PHARMACEUTICAL | 45,225 | 66,262 |
| SUPERNUS PHARMACEUTICALS | 16,577 | 43,740 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QCA FIRST FUND IV, LLC | AT COST | 7,674 | 7,674 |
| HEALTHCARE ASSET NETWORK, INC. | FMV | 101,180 | 160,773 |
| QCA FIRST FUND VI, LLC | AT COST | 67,961 | 67,961 |
| SERENE LLC | AT COST | 242,780 | 242,780 |
| PLANKKSTERS LLC | AT COST | 50,000 | 50,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ANNUAL REPORT FILING | 15 | 0 | 15 | |
| QCA IV | 132 | 132 | 0 | |
| INVESTMENT EXPENSES - PASS-THROUGH | 967 | 967 | 0 | |
| SERENE | 459 | 459 | 0 | |
| QCA VI | 5,833 | 5,833 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AGENCY & INVESTMENT FEES | 5,074 | 5,074 | 0 | |
| BANK FEES | 25 | 25 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 143 | 143 | 0 |